Filtrar la búsqueda

  • Libros (26)

a

Intervalo de precios personalizado (EUR)

a

Borden ernest c (26 resultados)

Autor: 
Refinar con la Búsqueda avanzada
  • Idioma: Inglés

    Editorial: Humana, 2002

    0896038769 / 9780896038769

    • Tapa dura

    Librería: Basi6 International, Irving, TX, Estados Unidos de AmericaBasi6 International

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 54,25

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 5 disponibles

    Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

  • Idioma: Inglés

    Editorial: Humana, 2002

    0896038769 / 9780896038769

    • Tapa dura

    Librería: Romtrade Corp., STERLING HEIGHTS, MI, Estados Unidos de AmericaRomtrade Corp.

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 54,25

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 1 disponible

    Condición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

  • Idioma: Inglés

    Editorial: Humana Press, 2002

    0896038769 / 9780896038769

    • Tapa dura

    Librería: Majestic Books, Hounslow, Reino UnidoMajestic Books

    Vendedor de 4 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 47,58

    Envío por EUR 7,79 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Condición: New. pp. xvi + 389 Illus.

  • Idioma: Inglés

    Editorial: Humana Press, 2002

    0896038769 / 9780896038769

    • Tapa dura

    Librería: Books Puddle, Woodside, NY, Estados Unidos de AmericaBooks Puddle

    Vendedor de 4 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 52,62

    Envío por EUR 3,62 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 1 disponible

    Condición: New. pp. xvi + 389.

  • Idioma: Inglés

    Editorial: Humana Press, 2002

    0896038769 / 9780896038769

    • Tapa dura

    Librería: Biblios, frankfurt am main, HESSE, AlemaniaBiblios

    Vendedor de 4 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 46,49

    Envío por EUR 9,95 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Condición: New. pp. xvi + 389.

  • Idioma: Inglés

    Editorial: Humana, 2002

    0896038769 / 9780896038769

    • Tapa dura

    Librería: Basi6 International, Irving, TX, Estados Unidos de AmericaBasi6 International

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 68,77

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 4 disponibles

    Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

  • Idioma: Inglés

    Editorial: Humana, 2002

    0896038769 / 9780896038769

    • Tapa dura

    Librería: Romtrade Corp., STERLING HEIGHTS, MI, Estados Unidos de AmericaRomtrade Corp.

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 68,77

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 1 disponible

    Condición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

  • Idioma: Inglés

    Editorial: Humana, 2012

    1468496689 / 9781468496680

    • Tapa blanda

    Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 77,96

    Envío por EUR 2,40 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 15 disponibles

    Condición: New.

  • Idioma: Inglés

    Editorial: Humana Press Inc, Totowa, New Jersey, USA, 2002

    0896038769 / 9780896038769

    • Tapa dura
    • Primera edición

    Librería: CURIO, Cleethorpes, North East Lincolnshire, Reino UnidoCURIO

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 43,22

    Envío por EUR 35,96 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Hardcover. Condición: New. No Jacket. 1st Edition. Brand New. First Edition / First Print (number line on copyright page 10 9 8 7 6 5 4 3 2 1). Hardback copy in pictorial boards, no dustjacket as issued. 389pp. Colour plates. Strategies of treatment involving therapeutic proteins, irnrnune immune cells, or cel­ lular protein targets are those of greatest potential for further reducing mortality from melanoma. Therapeutic proteins or cells may inhibit melanoma cell growth either by augmentation of immune cell function or by inhibition of angiogenesis. Cytokines and melanoma antigens may be used either in vivo as a vaccine to stimulate irnrnune immune cell cell function or ex vivo to stimulate or proliferate cells for infusion. Alternatively, alteration in melanoma cell growth can occur through inhibition of protein signal transduction pathways within melanoma cells or in the endothelial cells constituting the necessary angiogenic support for tumor growth. The great promise of these therapies and their cellular targets constitutes the basis for Melanoma: Biologically Targeted Therapeutics. THE CLINlCAL PROBLEM More than four million people will be diagnosed with melanoma in the first decade of the 21st century. Half of those who will die will be individuals who would otherwise have had a life expectancy of another 25 years or more. These individuals will die of systemic systernic metastases, which are present at the time of primary surgery. Despite use of sunscreens, incidence continues to increase in developed countries worldwide. To reduce mortality, there must continue to be a focus on prevention and earlier detection through public education. Early interventions are always preferable to treatment of disseminated metastatic disease. (35/1).…

  • Idioma: Inglés

    Editorial: Humana Press Inc., 2012

    1468496689 / 9781468496680

    • Tapa blanda

    Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandaKennys Bookshop and Art Galleries Ltd.

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 69,65

    Envío por EUR 9,50 
    Se envía de Irlanda a Estados Unidos de America

    Cantidad disponible: 15 disponibles

    Condición: New. Editor(s): Borden, Ernest C. Series: Current Clinical Oncology. Num Pages: 404 pages, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 22. Weight in Grams: 606. . 2012. Softcover reprint of the original 1st ed. 2002. Paperback. . . . . …

  • Idioma: Inglés

    Editorial: Humana Pr Inc, 2012

    1468496689 / 9781468496680

    • Tapa blanda

    Librería: Revaluation Books, Exeter, Reino UnidoRevaluation Books

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 84,28

    Envío por EUR 14,99 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Paperback. Condición: Brand New. reprint edition. 404 pages. 9.02x5.98x0.98 inches. In Stock.

  • Idioma: Inglés

    Editorial: Humana Press Inc., 2012

    1468496689 / 9781468496680

    • Tapa blanda

    Librería: Kennys Bookstore, Olney, MD, Estados Unidos de AmericaKennys Bookstore

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 90,64

    Envío por EUR 9,53 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 15 disponibles

    Condición: New. Editor(s): Borden, Ernest C. Series: Current Clinical Oncology. Num Pages: 404 pages, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 22. Weight in Grams: 606. . 2012. Softcover reprint of the original 1st ed. 2002. Paperback. . . . . Books ship from the US and Ireland. …

  • Idioma: Inglés

    Editorial: Humana Press, 2012

    1468496689 / 9781468496680

    • Tapa blanda

    Librería: moluna, Greven, Alemaniamoluna

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 47,23

    Envío por EUR 48,99 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    Condición: New.

  • Idioma: Inglés

    Editorial: Springer, Berlin, Humana, 2002

    0896038769 / 9780896038769

    • Tapa dura

    Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 67,23

    Envío por EUR 35,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Strategies of treatment involving therapeutic proteins, irnrnune immune cells, or cel lular protein targets are those of greatest potential for further reducing mortality from melanoma. Therapeutic proteins or cells may inhibit melanoma cell growth either by augmentation of immune cell function or by inhibition of angiogenesis. Cytokines and melanoma antigens may be used either in vivo as a vaccine to stimulate irnrnune immune cell cell function or ex vivo to stimulate or proliferate cells for infusion. Alternatively, alteration in melanoma cell growth can occur through inhibition of protein signal transduction pathways within melanoma cells or in the endothelial cells constituting the necessary angiogenic support for tumor growth. The great promise of these therapies and their cellular targets constitutes the basis for Melanoma: Biologically Targeted Therapeutics. THE CLINlCAL PROBLEM More than four million people will be diagnosed with melanoma in the first decade of the 21st century. Half of those who will die will be individuals who would otherwise have had a life expectancy of another 25 years or more. These individuals will die of systemic systernic metastases, which are present at the time of primary surgery. Despite use of sunscreens, incidence continues to increase in developed countries worldwide. To reduce mortality, there must continue to be a focus on prevention and earlier detection through public education. Early interventions are always preferable to treatment of disseminated metastatic disease.…

  • Idioma: Inglés

    Editorial: Humana, 2012

    1468496689 / 9781468496680

    • Tapa blanda

    Librería: Ria Christie Collections, Uxbridge, Reino UnidoRia Christie Collections

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 103,90

    Envío por EUR 13,44 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    Condición: New. In English.

  • Más imágenes

    Idioma: Inglés

    Editorial: Humana, 2012

    1468496689 / 9781468496680

    • Tapa blanda

    Librería: preigu, Osnabrück, Alemaniapreigu

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 50,65

    Envío por EUR 70,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 5 disponibles

    Taschenbuch. Condición: Neu. Melanoma | Biologically Targeted Therapeutics | Ernest C. Borden | Taschenbuch | Current Clinical Oncology | xvi | Englisch | 2012 | Humana | EAN 9781468496680 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

  • Idioma: Inglés

    Editorial: Humana, 2012

    1468496689 / 9781468496680

    • Tapa blanda

    Librería: Mispah books, Redhill, SURRE, Reino UnidoMispah books

    Vendedor de 4 estrellas
    Contactar con el vendedor

    Condición: Usado - Como Nuevo

    EUR 150,64

    Envío por EUR 29,97 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Paperback. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

  • Idioma: Inglés

    Editorial: Humana, 2012

    1468496689 / 9781468496680

    • Tapa blanda

    Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Usado - Como Nuevo

    EUR 183,55

    Envío por EUR 2,40 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 15 disponibles

    Condición: As New. Unread book in perfect condition.

  • Idioma: Inglés

    Editorial: SP HUMANA, 2002

    0896038769 / 9780896038769

    • Tapa dura
    • Edición internacional

    Librería: UK BOOKS STORE, London, LONDO, Reino UnidoUK BOOKS STORE

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 185,57

    Envío por EUR 4,78 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 4 disponibles

    Condición: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.…

  • Idioma: Inglés

    Editorial: Humana, 2002

    0896038769 / 9780896038769

    • Tapa dura

    Librería: SHIMEDIA, Brooklyn, NY, Estados Unidos de AmericaSHIMEDIA

    Vendedor de 4 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 373,81

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 1 disponible

    Condición: New. Satisfaction Guaranteed or your money back.

  • Idioma: Inglés

    Editorial: Humana, 2012

    1468496689 / 9781468496680

    • Tapa blanda
    • Impresión bajo demanda

    Librería: Brook Bookstore On Demand, Napoli, NA, ItaliaBrook Bookstore On Demand

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 46,22

    Envío por EUR 6,80 
    Se envía de Italia a Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    Condición: new. Questo è un articolo print on demand.

  • Idioma: Inglés

    Editorial: Berlin Humana Press Springer Apr 2002, 2002

    0896038769 / 9780896038769

    • Tapa dura
    • Impresión bajo demanda

    Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AlemaniaBuchWeltWeit Ludwig Meier e.K.

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 53,49

    Envío por EUR 23,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Strategies of treatment involving therapeutic proteins, irnrnune immune cells, or cel lular protein targets are those of greatest potential for further reducing mortality from melanoma. Therapeutic proteins or cells may inhibit melanoma cell growth either by augmentation of immune cell function or by inhibition of angiogenesis. Cytokines and melanoma antigens may be used either in vivo as a vaccine to stimulate irnrnune immune cell cell function or ex vivo to stimulate or proliferate cells for infusion. Alternatively, alteration in melanoma cell growth can occur through inhibition of protein signal transduction pathways within melanoma cells or in the endothelial cells constituting the necessary angiogenic support for tumor growth. The great promise of these therapies and their cellular targets constitutes the basis for Melanoma: Biologically Targeted Therapeutics. THE CLINlCAL PROBLEM More than four million people will be diagnosed with melanoma in the first decade of the 21st century. Half of those who will die will be individuals who would otherwise have had a life expectancy of another 25 years or more. These individuals will die of systemic systernic metastases, which are present at the time of primary surgery. Despite use of sunscreens, incidence continues to increase in developed countries worldwide. To reduce mortality, there must continue to be a focus on prevention and earlier detection through public education. Early interventions are always preferable to treatment of disseminated metastatic disease. 388 pp. Englisch.…

  • Idioma: Inglés

    Editorial: Humana Press Aug 2012, 2012

    1468496689 / 9781468496680

    • Tapa blanda
    • Impresión bajo demanda

    Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AlemaniaBuchWeltWeit Ludwig Meier e.K.

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 53,49

    Envío por EUR 23,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Strategies of treatment involving therapeutic proteins, irnrnune immune cells, or cel lular protein targets are those of greatest potential for further reducing mortality from melanoma. Therapeutic proteins or cells may inhibit melanoma cell growth either by augmentation of immune cell function or by inhibition of angiogenesis. Cytokines and melanoma antigens may be used either in vivo as a vaccine to stimulate irnrnune immune cell cell function or ex vivo to stimulate or proliferate cells for infusion. Alternatively, alteration in melanoma cell growth can occur through inhibition of protein signal transduction pathways within melanoma cells or in the endothelial cells constituting the necessary angiogenic support for tumor growth. The great promise of these therapies and their cellular targets constitutes the basis for Melanoma: Biologically Targeted Therapeutics. THE CLINlCAL PROBLEM More than four million people will be diagnosed with melanoma in the first decade of the 21st century. Half of those who will die will be individuals who would otherwise have had a life expectancy of another 25 years or more. These individuals will die of systemic systernic metastases, which are present at the time of primary surgery. Despite use of sunscreens, incidence continues to increase in developed countries worldwide. To reduce mortality, there must continue to be a focus on prevention and earlier detection through public education. Early interventions are always preferable to treatment of disseminated metastatic disease. 416 pp. Englisch.…

  • Idioma: Inglés

    Editorial: Humana Press 2012-08, 2012

    1468496689 / 9781468496680

    • Tapa blanda
    • Impresión bajo demanda

    Librería: Chiron Media, Wallingford, Reino UnidoChiron Media

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 91,45

    Envío por EUR 7,78 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 20 disponibles

    PF. Condición: New. This item is printed on demand. Brand new book, sourced directly from publisher. Dispatch time is 6-7 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.

  • Idioma: Inglés

    Editorial: Humana, 2012

    1468496689 / 9781468496680

    • Tapa blanda
    • Impresión bajo demanda

    Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 65,70

    Envío por EUR 35,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Strategies of treatment involving therapeutic proteins, irnrnune immune cells, or cel lular protein targets are those of greatest potential for further reducing mortality from melanoma. Therapeutic proteins or cells may inhibit melanoma cell growth either by augmentation of immune cell function or by inhibition of angiogenesis. Cytokines and melanoma antigens may be used either in vivo as a vaccine to stimulate irnrnune immune cell cell function or ex vivo to stimulate or proliferate cells for infusion. Alternatively, alteration in melanoma cell growth can occur through inhibition of protein signal transduction pathways within melanoma cells or in the endothelial cells constituting the necessary angiogenic support for tumor growth. The great promise of these therapies and their cellular targets constitutes the basis for Melanoma: Biologically Targeted Therapeutics. THE CLINlCAL PROBLEM More than four million people will be diagnosed with melanoma in the first decade of the 21st century. Half of those who will die will be individuals who would otherwise have had a life expectancy of another 25 years or more. These individuals will die of systemic systernic metastases, which are present at the time of primary surgery. Despite use of sunscreens, incidence continues to increase in developed countries worldwide. To reduce mortality, there must continue to be a focus on prevention and earlier detection through public education. Early interventions are always preferable to treatment of disseminated metastatic disease.…

  • Idioma: Inglés

    Editorial: Humana Aug 2012, 2012

    1468496689 / 9781468496680

    • Tapa blanda
    • Impresión bajo demanda

    Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemaniabuchversandmimpf2000

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 53,49

    Envío por EUR 60,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Strategies of treatment involving therapeutic proteins, irnrnune immune cells, or cel lular protein targets are those of greatest potential for further reducing mortality from melanoma. Therapeutic proteins or cells may inhibit melanoma cell growth either by augmentation of immune cell function or by inhibition of angiogenesis. Cytokines and melanoma antigens may be used either in vivo as a vaccine to stimulate irnrnune immune cell cell function or ex vivo to stimulate or proliferate cells for infusion. Alternatively, alteration in melanoma cell growth can occur through inhibition of protein signal transduction pathways within melanoma cells or in the endothelial cells constituting the necessary angiogenic support for tumor growth. The great promise of these therapies and their cellular targets constitutes the basis for Melanoma: Biologically Targeted Therapeutics. THE CLINlCAL PROBLEM More than four million people will be diagnosed with melanoma in the first decade of the 21st century. Half of those who will die will be individuals who would otherwise have had a life expectancy of another 25 years or more. These individuals will die of systemic systernic metastases, which are present at the time of primary surgery. Despite use of sunscreens, incidence continues to increase in developed countries worldwide. To reduce mortality, there must continue to be a focus on prevention and earlier detection through public education. Early interventions are always preferable to treatment of disseminated metastatic disease.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 416 pp. Englisch.…